Citation Impact
Citing Papers
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis
1994
Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling
2005
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism
2012
Albuminuria in Mice after Injection of Antibodies against Aminopeptidase A
2001 StandoutNobel
The prognostic importance of creatinine clearance after acute myocardial infarction
2002
Body Fatness and Cancer — Viewpoint of the IARC Working Group
2016 Standout
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Treatment of arterial hypertension in diabetic humans: Importance of therapeutic selection
1992
Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United States
2011
Diabetic renal disease: from recent studies to improved clinical practice
2004
Hypertension in mice lacking the gene for endothelial nitric oxide synthase
1995 StandoutNature
Primary aldosteronism
2011
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
2014 Standout
The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes
2001 Standout
Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes
2014
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
2001 Standout
Evaluation of the Modification of Diet in Renal Disease Study Equation in a Large Diverse Population
2007
Predictors of renal function following lung or heart-lung transplantation
2002
The metabolic syndrome
2010 Standout
Renal-Artery Stenosis
2001 Standout
Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study
1994
The gut–renal axis: do incretin-based agents confer renoprotection in diabetes?
2013
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement
2004
Effects of Smoking on Systemic and Intrarenal Hemodynamics
2004
Kidney function estimating equations: where do we stand?
2006
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
Uric Acid and Cardiovascular Risk
2008 Standout
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension
2003
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
2012 Standout
Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial
2005
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
2002
The metabolic syndrome
2005 Standout
Effect of 5-year enalapril therapy on progression of microalbuminuria and glomerular structural changes in type 1 diabetic subjects
2003
Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism
2008
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
2014 Standout
Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system
2005 StandoutNobel
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
2015 Standout
Interpreting different measures of glomerular filtration rate in obesity and weight loss: pitfalls for the clinician
2011
Renal function: the Cinderella of cardiovascular risk profile
2001
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
Long-Term Complications of Diabetes Mellitus
1993 Standout
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
2007 Standout
Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study
2000
Effect of Ramipril vs Amlodipine on Renal Outcomes in Hypertensive Nephrosclerosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001
Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor
1991 StandoutNature
Cardiac Dimensions Are Largely Determined by Dietary Salt in Patients with Primary Aldosteronism: Results of a Case-Control Study
2011
The renal risks of smoking
1997
Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension
1998
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
2008 Standout
The Hallmarks of Aging
2013 Standout
The effect of RAAS blockade on the progression of diabetic nephropathy
2013
Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis
2013
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013 Standout
Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice
1999 StandoutNobel
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on major adverse cardiac events in patients with newly diagnosed type 2 diabetes: A nationwide study
2015
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment
2000 StandoutNobel
Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus
1990
Hypertension Following Kidney Transplantation
1994
Prognostic Value of Angiotensin-I Converting Enzyme I/D Polymorphism for Nephropathy in Type 1 Diabetes Mellitus
2001
On the importance of estimating renal function for cardiovascular risk assessment
2004
Sympathetic Neural Mechanisms of Cyclosporine-Induced Hypertension*
1996
Lack of angiotensin II–facilitated erythropoiesis causes anemia in angiotensin-converting enzyme–deficient mice
2000 StandoutNobel
Diagnosis and Treatment of Primary Aldosteronism
2011
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition
2001
Mortality Rates in Trials of Subjects With Type 2 Diabetes
2012
Antihypertensive agents for preventing diabetic kidney disease
2012
A genetic model defines the importance of the atrial natriuretic peptide receptor (guanylyl cyclase-A) in the regulation of kidney function
2000
Predictors of Decreasing Glomerular Filtration Rate and Prevalence of Chronic Kidney Disease After Treatment of Primary Aldosteronism: Renal Outcome of 213 Cases
2013
Evaluating the performance of equations for estimating glomerular filtration rate.
2009
Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal ( CANVAS‐R ): A randomized, placebo‐controlled trial
2017
Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality, Cardiovascular Deaths, and Cardiovascular Events in Patients With Diabetes Mellitus
2014
Nifedipine Prevents Renal Injury in Rats With Chronic Nitric Oxide Inhibition
1995
Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse
2001 StandoutNobel
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Captopril or conventional therapy in hypertensive type II diabetics. Three-year analysis.
1993
Reduction of ACE Activity Is Insufficient to Decrease Microalbuminuria in Normotensive Patients With Type 1 Diabetes
2001
Serum Homocysteine Levels Are Associated With the Development of (Micro)albuminuria
2001
Role of Angiotensin Converting Enzyme Inhibitors in Essential and Renal Hypertension
1984
Prolonged Zona Glomerulosa Insufficiency Causing Hyperkalemia in Primary Aldosteronism after Adrenalectomy
2012
Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate
2006 Standout
Acute kidney injury: a springboard for progression in chronic kidney disease
2010
Angiotensin-Converting Enzyme Inhibitors
1998
Endothelial Dysfunction Is Related to Aldosterone Excess and Raised Blood Pressure
2009
Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group.
1994
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
Renal Dysfunction Complicating the Treatment of Hypertension
2002
Mechanisms of action of various hormones and vasoactive substances on glomerular ultrafiltration in the rat
1981
Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings
2000 StandoutNobel
Renal Considerations in Angiotensin Converting Enzyme Inhibitor Therapy
2001
Reversible Acute Renal Failure as an Atypical Presentation of Ischemic Nephropathy
1993
Sympathetic baroreceptor responses after chronic NG-nitro-L-arginine methyl ester treatment in conscious rats.
1994
Blood Pressure Lowering in Type 2 Diabetes
2015
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
2013 Standout
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
2004
Microalbuminuria as a Risk Predictor in Diabetes: The Continuing Saga
2014
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
2010 Standout
Intrarenal Hemodynamics in Primary Aldosteronism before and after Treatment
2009
Body mass index and risk of renal cell cancer: A dose‐response meta‐analysis of published cohort studies
2014
Interactions of Transforming Growth Factor-β and Angiotensin II in Renal Fibrosis
1998
Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
1994
Dietary Protein Intake and the Progressive Nature of Kidney Disease:
1982 Standout
Works of A Mimran being referenced
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study
2009
Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants
1993
Antioxidant supplementation and chronic renal transplant dysfunction
2000
Contrasting renal effects of nicotine in smokers and non-smokers
1998
Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
2011
The Future of Clinical Trials in Chronic Renal Disease: Outcome of an NIH/FDA/Physician Specialist Conference
2000
Office and ambulatory pulse pressure—association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study)
2010
Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy
1988
Relative Glomerular Hyperfiltration in Primary Aldosteronism
2005
Reversal of acute renal failure following percutaneous transluminal recanalization of an atherosclerotic renal artery occlusion
1989
Albuminuria in normals and essential hypertension
1994
A Comparison of the Effects of Mibefradil and Atenolol on Regression of Left Ventricular Hypertrophy in Hypertensive Patients
1998
Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study
2006
Glucose tolerance and age-associated decline in renal function of hypertensive patients
2001
Prevention of microalbuminuria in patients with type 2 diabetes and hypertension
2012
Endogenous Vasoactive Systems and the Pressor Effect of Acute N ω-Nitro-L-Arginine Methyl Ester Administration
1994
Renal Characteristics and Effect of Angiotensin Suppression in Oral Contraceptive Users
1999
Contrasting renal effects of chronic administrations of enalapril and losartan on one-kidney, one clip hypertensive rats
1998
Sodium restriction prevents cardiac hypertrophy and oxidative stress in angiotensin II hypertension
2003
Albuminuria in untreated patients with primary aldosteronism or essential hypertension
1995
Acute renal effects of captopril in patients with congestive heart failure.
1986
Microalbuminuria in Essential Hypertension
1993
Prevention of the Cardiovascular and Renal Effects of Angiotensin II by Endothelin Blockade
1998
Angiotensin-Converting Enzyme Inhibitors Versus Calcium Antagonists in the Progression of Renal Diseases
1994
Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade.
1993
Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
2012
[Arterial hypertension and diabetes. Members of the Board of Directors and Scientific Directors of ALFEDIAM].
1996
Comparative Effect of Captopril and Nifedipine in Normotensive Patients With Incipient Diabetic Nephropathy
1988
Combined Renal Effects of Overweight and Hypertension
1995
Microalbuminuria in Type 2 Diabetes and Hypertension
2008
The antihypertensive effect of captopril. Evidence for an influence of kinins.
1980
Effect of a Competitive Angiotensin Antagonist on the Renal Haemodynamic Changes Induced by Inhibition of Prostaglandin Synthesis in Rats
1974
Renal changes associated with cyclosporine in recent type I diabetes mellitus.
1991
The renin-angiotensin system and renal function in kidney transplantation.
1990
Effect of Captopril on Renal Vascular Tone in Patients with Essential Hypertension
1979
Estimation of Renal Function in Subjects With Normal Serum Creatinine Levels: Influence of Age and Body Mass Index
2005
Dietary Sodium, Aldosterone, and Left Ventricular Mass Changes During Long-Term Inhibition of the Renin-Angiotensin System
2010
Antihypertensive therapy in renal disease and transplantation
1992
Response of atrial natriuretic peptide to acute saline loading in essential hypertension
1988
Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy.
1988
Is microalbuminuria a marker of early intrarenal vascular dysfunction in essential hypertension?
1994